|
Study of the antinociceptive activity of fluoxetine and its interaction with morphine and naloxone in mice
PN Kurlekar, Jagat D Bhatt
Department of Pharmacology, Medical College, Baroda - 390 001, India
Correspondence Address:
Jagat D Bhatt
Department of Pharmacology, Medical College, Baroda - 390 001
OBJECTIVE: To study the probable site of the antinociceptive action of fluoxetine and its interaction with morphine and naloxone.
MATERIAL AND METHODS: The antinociceptive activity of fluoxetine was studied using tail-flick method in the absence and presence of naloxone in mice. Different doses of fluoxetine (2, 5 and 10 mg/kg) and morphine (0.5 mg/kg and 1 mg/kg) were administered subcutaneously to select the subanalgesic doses for both. Subanalgesic doses of both the drugs were administered simultaneously to study their interaction on tail-flick latency.
RESULTS: Fluoxetine and morphine produced a dose-dependent antinociceptive action. Combination of the subanalgesic dose of both fluoxetine (2 mg/kg) and morphine (0.5 mg/kg) produced an additive effect. Naloxone in a dose of 1 mg/kg produced a significant (P<0. 001) hyperalgesia at time intervals of 15, 30 and 60 min while in a dose of 2 mg/kg it produced significant (P<0. 001) hyperalgesia at time intervals of 30, 60 and 120 min. Naloxone (2 mg/kg) pretreatment significantly reduced the antinociception produced by fluoxetine.
CONCLUSION: Analgesia produced by fluoxetine may be mediated by «SQ»micro«SQ» opioid receptor, however, mechanisms involving other endogenous opioid peptides could not be ruled out. Fluoxetine as a monotherapy or in combination with other opioids could be useful in the management of pain.
How to cite this article:
Kurlekar P N, Bhatt JD. Study of the antinociceptive activity of fluoxetine and its interaction with morphine and naloxone in mice.Indian J Pharmacol 2004;36:369-372
|
How to cite this URL:
Kurlekar P N, Bhatt JD. Study of the antinociceptive activity of fluoxetine and its interaction with morphine and naloxone in mice. Indian J Pharmacol [serial online] 2004 [cited 2023 Mar 31 ];36:369-372
Available from: https://www.ijp-online.com/article.asp?issn=0253-7613;year=2004;volume=36;issue=6;spage=369;epage=372;aulast=Kurlekar;type=0 |
|
